Nuveen Asset Management’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $494K | Buy |
345,192
+69,377
| +25% | +$99.2K | ﹤0.01% | 2990 |
|
2024
Q3 | $532K | Hold |
275,815
| – | – | ﹤0.01% | 2997 |
|
2024
Q2 | $855K | Sell |
275,815
-10,990
| -4% | -$34.1K | ﹤0.01% | 2791 |
|
2024
Q1 | $1.5M | Buy |
286,805
+129,969
| +83% | +$680K | ﹤0.01% | 2525 |
|
2023
Q4 | $508K | Buy |
156,836
+336
| +0.2% | +$1.09K | ﹤0.01% | 2992 |
|
2023
Q3 | $399K | Sell |
156,500
-3,825
| -2% | -$9.75K | ﹤0.01% | 2911 |
|
2023
Q2 | $941K | Buy |
160,325
+85,766
| +115% | +$503K | ﹤0.01% | 2678 |
|
2023
Q1 | $212K | Buy |
74,559
+20,071
| +37% | +$57.1K | ﹤0.01% | 2982 |
|
2022
Q4 | $110K | Sell |
54,488
-22,128
| -29% | -$44.7K | ﹤0.01% | 3101 |
|
2022
Q3 | $222K | Sell |
76,616
-120
| -0.2% | -$348 | ﹤0.01% | 3101 |
|
2022
Q2 | $432K | Buy |
76,736
+24,997
| +48% | +$141K | ﹤0.01% | 3055 |
|
2022
Q1 | $564K | Buy |
51,739
+21,031
| +68% | +$229K | ﹤0.01% | 2982 |
|
2021
Q4 | $580K | Buy |
30,708
+10,273
| +50% | +$194K | ﹤0.01% | 3038 |
|
2021
Q3 | $422K | Buy |
+20,435
| New | +$422K | ﹤0.01% | 3199 |
|